| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |